{"id":"NCT01828099","sponsor":"Novartis Pharmaceuticals","briefTitle":"LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer","officialTitle":"A Phase III Multicenter, Randomized Study of Oral LDK378 Versus Standard Chemotherapy in Previously Untreated Adult Patients With ALK Rearranged (ALK-positive), Stage IIIB or IV, Non-squamous Non-small Cell Lung Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07-09","primaryCompletion":"2016-06-24","completion":"2024-01-07","firstPosted":"2013-04-10","resultsPosted":"2017-09-21","lastUpdate":"2025-01-16"},"enrollment":376,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-Small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"Ceritinib","otherNames":["LDK378"]},{"type":"DRUG","name":"Pemetrexed","otherNames":[]},{"type":"DRUG","name":"Cisplatin","otherNames":[]},{"type":"DRUG","name":"Carboplatin","otherNames":[]}],"arms":[{"label":"Ceritinib","type":"EXPERIMENTAL"},{"label":"Chemotherapy","type":"ACTIVE_COMPARATOR"}],"summary":"To compare the efficacy and safety of ceritinib with standard first-line chemotherapy (pemetrexed plus cisplatin or carboplatin) in patients with stage IIIB (not candidates for definitive multimodality therapy) or stage IV, non-squamous non-small cell lung cancer (NSCLC) harboring a confirmed anaplastic lymphoma kinase (ALK) rearrangement, using the Ventana immunohistochemistry (IHC) test.","primaryOutcome":{"measure":"Progression Free Survival (PFS) by Blinded Independent Review Committee (BIRC)","timeFrame":"From the date of randomization to the date of first radiologically documented disease progression or death due to any cause, up to approximately 34 months","effectByArm":[{"arm":"Ceritinib","deltaMin":16.6,"sd":null},{"arm":"Chemotherapy","deltaMin":8.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":167,"countries":["Argentina","Australia","Austria","Brazil","China","Colombia","Denmark","France","Germany","Greece","Hungary","India","Ireland","Italy","Japan","Lebanon","Mexico","Netherlands","Norway","Poland","Russia","Singapore","South Korea","Spain","Sweden","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["28126333","27130468"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":93,"n":189},"commonTop":["Nausea","Diarrhoea","Vomiting","Alanine aminotransferase increased","Aspartate aminotransferase increased"]}}